Insider · CIK 0002050085
Vikas Mittal
Files at KOYN (CSLM Digital Asset Acquisition Corp III, Ltd). First filing -, latest -.
In brief
Vikas Mittal files SEC Form 4 as CFO, chair, director and 10% owner at KOYN (CSLM Digital Asset Acquisition Corp III, Ltd). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Vikas Mittal has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 28, 2025 | KOYN CSLM Digital Asset Acquisition Corp III, Ltd | POpen-market purchase Class A ordinary sharesindirect: See Footnote | +575,000 | - | - | 575,000 | Aug 28, 2025 |
| Aug 28, 2025 | KOYN CSLM Digital Asset Acquisition Corp III, Ltd | POpen-market purchase Warrants to purchase Class A ordinary sharesderivativeindirect: See Footnote | +287,500 | - | - | 287,500 | Aug 28, 2025 |
Questions about Vikas Mittal
Answered from the filings on this page, as of the latest one.
Is Vikas Mittal buying or selling?
Vikas Mittal has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Vikas Mittal's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Vikas Mittal has 0.
Where does Vikas Mittal file Form 4?
Vikas Mittal has filed Form 4 at KOYN (CSLM Digital Asset Acquisition Corp III, Ltd) as Chairman and CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.